Literature DB >> 17805517

A potential function of endocannabinoids in the selection of a navigation strategy by rats.

Pavel E Rueda-Orozco1, Edgar Soria-Gomez, Corinne J Montes-Rodriguez, Marina Martínez-Vargas, Oscar Galicia, Luz Navarro, Oscar Prospero-García.   

Abstract

RATIONALE: One of the adaptive abilities of the brain is the generation of a strategy to optimize acquisition of information, i.e., learning. In this study, we explored the role of environmental conditions (the light-dark cycle) and of the endocannabinoid anandamide in rats to select a strategy to solve the Barnes maze (BM).
OBJECTIVES: To determine the effects of manipulating the cannabinergic system on a spatial task in relation to the light-dark cycle.
MATERIALS AND METHODS: Rats received an intrahippocampal or intrastriatal administration of anandamide, AM251, or their combination at two different points of the light-dark cycle (1300 and 0100 hours), and their performance in the BM was evaluated. In addition, we determined the expression of the cannabinoid 1 receptor (CB1R) in the hippocampus and striatum throughout the light-dark cycle.
RESULTS: Results indicate that rats solved the BM by using a spatial strategy during the light phase and a procedural (serial) strategy during the dark phase of the cycle. CB1R expression varied in the hippocampus, being higher at 1300 hours and lower at 0100 hours, whereas its expression remained unchanged in the striatum.
CONCLUSIONS: Changes in the brain, which include changes in the endocannabinoid system, prompt it to use different strategies (spatial and procedural, or others not evaluated in this study) to cope with the environmental demands. These cerebral changes are adaptive responses to the light-dark cycle.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17805517     DOI: 10.1007/s00213-007-0911-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  44 in total

1.  Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB.

Authors:  M Egertová; M R Elphick
Journal:  J Comp Neurol       Date:  2000-06-26       Impact factor: 3.215

2.  Molecular composition of the endocannabinoid system at glutamatergic synapses.

Authors:  István Katona; Gabriella M Urbán; Matthew Wallace; Catherine Ledent; Kwang-Mook Jung; Daniele Piomelli; Ken Mackie; Tamás F Freund
Journal:  J Neurosci       Date:  2006-05-24       Impact factor: 6.167

3.  Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system.

Authors:  K Tsou; S Brown; M C Sañudo-Peña; K Mackie; J M Walker
Journal:  Neuroscience       Date:  1998-03       Impact factor: 3.590

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Oleamide modulates memory in rats.

Authors:  E Murillo-Rodríguez; M Giordano; R Cabeza; S J Henriksen; M Méndez Díaz; L Navarro; O Prospéro-García
Journal:  Neurosci Lett       Date:  2001-11-02       Impact factor: 3.046

6.  Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis.

Authors:  Attila Köfalvi; Ricardo J Rodrigues; Catherine Ledent; Ken Mackie; E Sylvester Vizi; Rodrigo A Cunha; Beáta Sperlágh
Journal:  J Neurosci       Date:  2005-03-16       Impact factor: 6.167

7.  GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus.

Authors:  I Katona; B Sperlágh; Z Maglóczky; E Sántha; A Köfalvi; S Czirják; K Mackie; E S Vizi; T F Freund
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

8.  Postsynaptic endocannabinoid release is critical to long-term depression in the striatum.

Authors:  G L Gerdeman; J Ronesi; D M Lovinger
Journal:  Nat Neurosci       Date:  2002-05       Impact factor: 24.884

9.  Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum.

Authors:  B Szabo; L Dörner; C Pfreundtner; W Nörenberg; K Starke
Journal:  Neuroscience       Date:  1998-07       Impact factor: 3.590

10.  Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain.

Authors:  M Valenti; D Viganò; M G Casico; T Rubino; L Steardo; D Parolaro; V Di Marzo
Journal:  Cell Mol Life Sci       Date:  2004-04       Impact factor: 9.261

View more
  16 in total

1.  Circadian rhythm of circulating levels of the endocannabinoid 2-arachidonoylglycerol.

Authors:  E C Hanlon; E Tasali; R Leproult; K L Stuhr; E Doncheck; H de Wit; C J Hillard; E Van Cauter
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

2.  Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide).

Authors:  Erin C Hanlon
Journal:  Psychoneuroendocrinology       Date:  2019-10-04       Impact factor: 4.905

3.  Chronic Silymarin, Quercetin and Naringenin Treatments Increase Monoamines Synthesis and Hippocampal Sirt1 Levels Improving Cognition in Aged Rats.

Authors:  F Sarubbo; M R Ramis; C Kienzer; S Aparicio; S Esteban; A Miralles; D Moranta
Journal:  J Neuroimmune Pharmacol       Date:  2017-08-14       Impact factor: 4.147

Review 4.  Endocannabinoid signalling: has it got rhythm?

Authors:  Linda K Vaughn; Gerene Denning; Kara L Stuhr; Harriet de Wit; Matthew N Hill; Cecilia J Hillard
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

5.  Threat-induced modulation of hippocampal and striatal memory systems during navigation of a virtual environment.

Authors:  Jarid Goodman; Mason McClay; Joseph E Dunsmoor
Journal:  Neurobiol Learn Mem       Date:  2020-01-07       Impact factor: 2.877

6.  Unbalanced Inhibitory/Excitatory Responses in the Substantia Nigra Pars Reticulata Underlie Cannabinoid-Related Slowness of Movements.

Authors:  Ana S Báez-Cordero; Ana K Pimentel-Farfan; Teresa Peña-Rangel; Pavel E Rueda-Orozco
Journal:  J Neurosci       Date:  2020-06-12       Impact factor: 6.167

7.  Terminal field and firing selectivity of cholecystokinin-expressing interneurons in the hippocampal CA3 area.

Authors:  Bálint Lasztóczi; John J Tukker; Peter Somogyi; Thomas Klausberger
Journal:  J Neurosci       Date:  2011-12-07       Impact factor: 6.167

Review 8.  Effects of Cannabis Consumption on Sleep.

Authors:  Alejandra Mondino; Matías Cavelli; Joaquín González; Eric Murillo-Rodriguez; Pablo Torterolo; Atilio Falconi
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  A Pilot Study into the Effects of the CB1 Cannabinoid Receptor Agonist WIN55,212-2 or the Antagonist/Inverse Agonist AM251 on Sleep in Rats.

Authors:  Anushka V Goonawardena; Andrea Plano; Lianne Robinson; Bettina Platt; Robert E Hampson; Gernot Riedel
Journal:  Sleep Disord       Date:  2012-01-04

10.  Does the neuroprotective role of anandamide display diurnal variations?

Authors:  Marina Martinez-Vargas; Julio Morales-Gomez; Ruben Gonzalez-Rivera; Carla Hernandez-Enriquez; Adan Perez-Arredondo; Francisco Estrada-Rojo; Luz Navarro
Journal:  Int J Mol Sci       Date:  2013-11-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.